These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9815213)

  • 21. Herpes simplex virus shedding among human immunodeficiency virus-negative men who have sex with men: site and frequency of shedding.
    Krone MR; Tabet SR; Paradise M; Wald A; Corey L; Celum CL
    J Infect Dis; 1998 Oct; 178(4):978-82. PubMed ID: 9806024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women.
    van Benthem BH; Spaargaren J; van Den Hoek JA; Merks J; Coutinho RA; Prins M;
    Sex Transm Infect; 2001 Apr; 77(2):120-4. PubMed ID: 11287691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe.
    Gwanzura L; McFarland W; Alexander D; Burke RL; Katzenstein D
    J Infect Dis; 1998 Feb; 177(2):481-4. PubMed ID: 9466543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.
    Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ
    Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
    Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
    J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
    Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
    Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.
    Tan DH; Raboud JM; Kaul R; Brunetta J; Kaushic C; Kovacs C; Lee E; Luetkehoelter J; Rachlis A; Smaill F; Smieja M; Walmsley SL
    Clin Infect Dis; 2013 Aug; 57(3):448-57. PubMed ID: 23572481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinician and patient recognition of anogenital herpes disease in HIV positive men who have sex with men.
    Sandlin MI; Johnston C; Bowe D; Saracino M; Schacker T; Shaughnessy M; Corey L; Wald A
    Sex Transm Dis; 2011 Sep; 38(9):833-6. PubMed ID: 21844739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru.
    Lama JR; Lucchetti A; Suarez L; Laguna-Torres VA; Guanira JV; Pun M; Montano SM; Celum CL; Carr JK; Sanchez J; Bautista CT; Sanchez JL;
    J Infect Dis; 2006 Nov; 194(10):1459-66. PubMed ID: 17054077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.
    Schacker T; Ryncarz AJ; Goddard J; Diem K; Shaughnessy M; Corey L
    JAMA; 1998 Jul; 280(1):61-6. PubMed ID: 9660365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe.
    Cowan FF; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Latif AS; Bassett MT; Wilson D; Brown DW; Hayes RJ
    AIDS; 2006 Jan; 20(2):261-7. PubMed ID: 16511420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and correlates of herpes simplex virus type-2 infection among men who have sex with men, san francisco, 2008.
    Bohl DD; Katz KA; Bernstein K; Wong E; Raymond HF; Klausner JD; McFarland W
    Sex Transm Dis; 2011 Jul; 38(7):617-21. PubMed ID: 21278625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.
    Tobian AA; Grabowski MK; Serwadda D; Newell K; Ssebbowa P; Franco V; Nalugoda F; Wawer MJ; Gray RH; Quinn TC; Reynolds SJ;
    J Infect Dis; 2013 Sep; 208(5):839-46. PubMed ID: 23812240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time.
    Benedetti JK; Zeh J; Corey L
    Ann Intern Med; 1999 Jul; 131(1):14-20. PubMed ID: 10391810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
    Delany S; Mlaba N; Clayton T; Akpomiemie G; Capovilla A; Legoff J; Belec L; Stevens W; Rees H; Mayaud P
    AIDS; 2009 Feb; 23(4):461-9. PubMed ID: 19155993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.
    Zuckerman RA; Lucchetti A; Whittington WL; Sánchez J; Coombs RW; Magaret A; Wald A; Corey L; Celum C
    AIDS; 2009 Feb; 23(4):479-83. PubMed ID: 19169140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers.
    Aumakhan B; Gaydos CA; Quinn TC; Beyrer C; Benning L; Minkoff H; Merenstein DJ; Cohen M; Greenblatt R; Nowicki M; Anastos K; Gange SJ
    PLoS One; 2010 Apr; 5(4):e9973. PubMed ID: 20376310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.
    Nagot N; Ouedraogo A; Konate I; Weiss HA; Foulongne V; Defer MC; Sanon A; Becquart P; Segondy M; Sawadogo A; Van de Perre P; Mayaud P;
    J Infect Dis; 2008 Jul; 198(2):241-9. PubMed ID: 18593294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania.
    Tanton C; Weiss HA; LeGoff J; Changalucha J; Clayton TC; Ross DA; Belec L; Hayes RJ; Watson-Jones D
    Sex Transm Infect; 2011 Aug; 87(5):406-11. PubMed ID: 21653932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.